1. Home
  2. PAYC vs RGEN Comparison

PAYC vs RGEN Comparison

Compare PAYC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paycom Software Inc.

PAYC

Paycom Software Inc.

HOLD

Current Price

$218.13

Market Cap

7.6B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$166.83

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAYC
RGEN
Founded
1998
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
6.6B
IPO Year
2014
1995

Fundamental Metrics

Financial Performance
Metric
PAYC
RGEN
Price
$218.13
$166.83
Analyst Decision
Buy
Buy
Analyst Count
15
12
Target Price
$168.79
$167.67
AVG Volume (30 Days)
890.8K
1.3M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
1.17%
N/A
EPS Growth
N/A
286.96
EPS
5.43
0.24
Revenue
$433,047,000.00
$141,236,000.00
Revenue This Year
$8.79
$14.30
Revenue Next Year
$7.48
$14.52
P/E Ratio
$41.25
$698.10
Revenue Growth
N/A
35.10
52 Week Low
$104.90
$100.99
52 Week High
$234.60
$175.77

Technical Indicators

Market Signals
Indicator
PAYC
RGEN
Relative Strength Index (RSI) 76.01 71.07
Support Level $114.49 $156.65
Resistance Level N/A $173.10
Average True Range (ATR) 8.92 6.99
MACD 4.32 1.79
Stochastic Oscillator 90.54 96.87

Price Performance

Historical Comparison
PAYC
RGEN

About PAYC Paycom Software Inc.

Paycom is a cloud-based human capital management provider offering payroll, compliance, and human resources management solutions. The firm's solutions are available on a unified, modular platform, and customers are billed for access on a subscription basis. Paycom's customer base skews toward the midmarket and is primarily based in North America. As of 2025, the firm manages records for 7.4 million employees across more than 20,000 clients on a parent-company-group basis.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: